rs3803

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032638.5(GATA2):​c.*482C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 251,374 control chromosomes in the GnomAD database, including 3,943 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2468 hom., cov: 33)
Exomes 𝑓: 0.16 ( 1475 hom. )

Consequence

GATA2
NM_032638.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.819

Publications

23 publications found
Variant links:
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
GATA2 Gene-Disease associations (from GenCC):
  • deafness-lymphedema-leukemia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • GATA2 deficiency with susceptibility to MDS/AML
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • monocytopenia with susceptibility to infections
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • myelodysplastic syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-128480537-G-A is Benign according to our data. Variant chr3-128480537-G-A is described in ClinVar as Benign. ClinVar VariationId is 343123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.192 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATA2NM_032638.5 linkc.*482C>T 3_prime_UTR_variant Exon 6 of 6 ENST00000341105.7 NP_116027.2 P23769-1
GATA2NM_001145661.2 linkc.*482C>T 3_prime_UTR_variant Exon 7 of 7 NP_001139133.1 P23769-1
GATA2NM_001145662.1 linkc.*482C>T 3_prime_UTR_variant Exon 6 of 6 NP_001139134.1 P23769-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATA2ENST00000341105.7 linkc.*482C>T 3_prime_UTR_variant Exon 6 of 6 1 NM_032638.5 ENSP00000345681.2 P23769-1

Frequencies

GnomAD3 genomes
AF:
0.174
AC:
26494
AN:
152006
Hom.:
2467
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.173
Gnomad AMI
AF:
0.204
Gnomad AMR
AF:
0.157
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.0549
Gnomad SAS
AF:
0.0728
Gnomad FIN
AF:
0.194
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.195
Gnomad OTH
AF:
0.181
GnomAD4 exome
AF:
0.164
AC:
16278
AN:
99250
Hom.:
1475
Cov.:
0
AF XY:
0.165
AC XY:
7685
AN XY:
46594
show subpopulations
African (AFR)
AF:
0.163
AC:
709
AN:
4358
American (AMR)
AF:
0.139
AC:
433
AN:
3124
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
723
AN:
5614
East Asian (EAS)
AF:
0.0514
AC:
651
AN:
12656
South Asian (SAS)
AF:
0.0904
AC:
85
AN:
940
European-Finnish (FIN)
AF:
0.157
AC:
311
AN:
1982
Middle Eastern (MID)
AF:
0.187
AC:
108
AN:
578
European-Non Finnish (NFE)
AF:
0.190
AC:
11837
AN:
62254
Other (OTH)
AF:
0.183
AC:
1421
AN:
7744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
775
1551
2326
3102
3877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.174
AC:
26509
AN:
152124
Hom.:
2468
Cov.:
33
AF XY:
0.171
AC XY:
12738
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.172
AC:
7156
AN:
41496
American (AMR)
AF:
0.156
AC:
2394
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
407
AN:
3472
East Asian (EAS)
AF:
0.0549
AC:
284
AN:
5176
South Asian (SAS)
AF:
0.0737
AC:
355
AN:
4818
European-Finnish (FIN)
AF:
0.194
AC:
2057
AN:
10600
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.195
AC:
13239
AN:
67942
Other (OTH)
AF:
0.179
AC:
378
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1076
2151
3227
4302
5378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.187
Hom.:
7020
Bravo
AF:
0.174
Asia WGS
AF:
0.0720
AC:
250
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Benign:1
Feb 11, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deafness-lymphedema-leukemia syndrome Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.1
DANN
Benign
0.74
PhyloP100
0.82
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3803; hg19: chr3-128199380; API